105 Background: Sexual preservation is an important issue in the treatment of localized
prostate cancer. In this study, we evaluate the long-term incidence of erectile dysfunction …

Background: We evaluated the long-term health-related quality of life (HRQoL) after modern
prostate brachytherapy (PB). Patients and Methods: The European Organization for …

Purpose: Evaluate erectile dysfunction (ED) following brachytherapy with dose escalation to
biological target volumes (BTV) identified by prostate-specific membrane antigen (PSMA) …

METHODS The prospective, population-based Comparative Effectiveness Analysis of
Surgery and Radiation (CEASAR) study enrolled men with localized prostate cancer in 2011 …

Purpose The aim of this study was to evaluate quality-of-life changes up to 10 years
following three different radiotherapy concepts. Methods and Materials In the years 2000 …

Following definitive local treatment for early-stage prostate cancer, preservation of erectile
function has been assumed to be most likely following brachytherapy. However, recent …

Purpose/Objective: To prospectively assess health-related quality of life (HRQOL) during the
first year after treatment with prostate brachytherapy (PB) alone for T1c-2a prostate cancer …

To determine the risk factors for EDin men treated by prostate brachytherapy (PB) for
localized prostate cancer and to propose a model to predict post-implant erectile function …

Purpose: We sought to compare changes in patient-reported quality of life (PRQOL)
following stereotactic body radiation therapy (SBRT), high dose rate (HDR), and low dose …

Results Of the 253 pts analyzed, 169 had normal sexual function before treatment and
56/169 developed post implant ED. The overall rate of ED was 33.1%(18.3% for HDR and …